Ten individuals from Rice University have been named to the second cohort of the Innovation Fellowship program. Photos via Rice.edu

A program with a mission to translate research into innovative startups has named its 2023 cohort of fellows.

Rice University's Innovation Fellows program, which is run by the Liu Idea Lab for Innovation and Entrepreneurship and the Office of Innovation, has announced the 10 innovators that will be joining the program this year. The program, open to Rice faculty and doctoral and postdoctoral students, provides support — funding, mentorship, and more — to move innovation out of labs and into commercialization.

“The Rice Innovation Fellows program is a critical part of our efforts to support innovation and entrepreneurship,” Rice President Reginald DesRoches says in a news release. “These exceptional individuals represent some of the most innovative and promising research being conducted at Rice, and we’re thrilled to support them as they work to bring their ideas to the world.”

According to the release, the 10 members of the 2023 cohort are:

  • Martha Fowler, a doctoral student from the bioengineering lab of Omid Veiseh
  • Carson Cole, a doctoral student from the chemistry lab of Jeff Hartgerink
  • Fatima Ahsan, a doctoral student from the electrical and computer engineering lab of Behnaam Aazhang
  • Siraj Sidhik, a doctoral student from the materials science and nanoengineering lab of Aditya Mohite
  • Roman Zhuravel, a postdoctoral student from the physics and astronomy lab of Guido Pagano
  • Samira Aghlara-Fotovat, a doctoral student from the bioengineering lab of Veiseh
  • Clarke Wilkirson, a doctoral student from the mechanical engineering lab of Peter Lillehoj
  • Yuren Feng, a doctoral student from the civil and environmental engineering lab of Qilin Li
  • Yang Xia, a doctoral student from the chemical and molecular engineering lab of Haotian Wang
  • Thao Vy Nguyen, a doctoral student from the chemical engineering lab of Sibani Lisa Biswal

Each of Rice's Innovation Fellows will receive up to $20,000 in funding, as well as access to the university's network for mentorship and training.

“We're incredibly excited to welcome this exceptional group of researchers into the Innovation Fellows program,” says Yael Hochberg, head of the Rice Entrepreneurship Initiative and faculty director for Lilie, in the release. “We look forward to working with them as they bring their groundbreaking research to market and make a real impact on the world.”

Last year's inaugural cohort in raised more than $1 million in venture capital funding and over $3 million in additional nondilutive funding, as well as earning more than $500,000 in revenue.

Some of the 2022 cohort's accomplishments included Helix Earth Technologies winning the inaugural TEX-E Prize and Sygne Solutions securing second place and $200,000 at the 2023 Rice Business Plan Competition.

Paul Cherukuri, Rice’s vice president for innovation, who recently joined the Houston Innovators Podcast, explains how this is one avenue Rice has for getting innovation off campus and into industry.

“With commercialization of research at the forefront of what Rice University wants to do,” says Cherukuri, "the Innovation Fellows program is the first in a constellation of programs and resources developed by the Office of Innovation to help impactful new ventures overcome the hard tech ‘valley of death’ and transition from the campus to the community, so we can help create the next generation of game-changing company for Houston, Texas and the world,."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Rice University lands $18M to revolutionize lymphatic disease detection

fresh funding

An arm of the U.S. Department of Health and Human Services has awarded $18 million to scientists at Rice University for research that has the potential to revolutionize how lymphatic diseases are detected and help increase survivability.

The lymphatic system is the network of vessels all over the body that help eliminate waste, absorb fat and maintain fluid balance. Diseases in this system are often difficult to detect early due to the small size of the vessels and the invasiveness of biopsy testing. Though survival rates of lymph disease have skyrocketed in the United States over the last five years, it still claims around 200,000 people in the country annually.

Early detection of complex lymphatic anomalies (CLAs) and lymphedema is essential in increasing successful treatment rates. That’s where Rice University’s SynthX Center, directed by Han Xiao and Lei Li, an assistant professor of electrical and computer engineering, comes in.

Aided by researchers from Texas Children’s Hospital, Baylor College of Medicine, the University of Texas at Dallas and the University of Texas Southwestern Medical Center, the center is pioneering two technologies: the Visual Imaging System for Tracing and Analyzing Lymphatics with Photoacoustics (VISTA-LYMPH) and Digital Plasmonic Nanobubble Detection for Protein (DIAMOND-P).

Simply put, VISTA-LYMPH uses photoacoustic tomography (PAT), a combination of light and sound, to more accurately map the tiny vessels of the lymphatic system. The process is more effective than diagnostic tools that use only light or sound, independent of one another. The research award is through the Advanced Research Projects Agency for Health (ARPA-H) Lymphatic Imaging, Genomics and pHenotyping Technologies (LIGHT) program, part of the U.S. HHS, which saw the potential of VISTA-LYMPH in animal tests that produced finely detailed diagnostic maps.

“Thanks to ARPA-H’s award, we will build the most advanced PAT system to image the body’s lymphatic network with unprecedented resolution and speed, enabling earlier and more accurate diagnosis,” Li said in a news release.

Meanwhile, DIAMOND-P could replace the older, less exact immunoassay. It uses laser-heated vapors of plasmonic nanoparticles to detect viruses without having to separate or amplify, and at room temperature, greatly simplifying the process. This is an important part of greater diagnosis because even with VISTA-LYMPH’s greater imaging accuracy, many lymphatic diseases still do not appear. Detecting biological markers is still necessary.

According to Rice, the efforts will help address lymphatic disorders, including Gorham-Stout disease, kaposiform lymphangiomatosis and generalized lymphatic anomaly. They also could help manage conditions associated with lymphatic dysfunction, including cancer metastasis, cardiovascular disease and neurodegeneration.

“By validating VISTA-LYMPH and DIAMOND-P in both preclinical and clinical settings, the team aims to establish a comprehensive diagnostic pipeline for lymphatic diseases and potentially beyond,” Xiao added in the release.

The ARPA-H award funds the project for up to five years.

Houston doctor wins NIH grant to test virtual reality for ICU delirium

Virtual healing

Think of it like a reverse version of The Matrix. A person wakes up in a hospital bed and gets plugged into a virtual reality game world in order to heal.

While it may sound far-fetched, Dr. Hina Faisal, a Houston Methodist critical care specialist in the Department of Surgery, was recently awarded a $242,000 grant from the National Institute of Health to test the effects of VR games on patients coming out of major surgery in the intensive care unit (ICU).

The five-year study will focus on older patients using mental stimulation techniques to reduce incidences of delirium. The award comes courtesy of the National Institute on Aging K76 Paul B. Beeson Emerging Leaders Career Development Award in Aging.

“As the population of older adults continues to grow, the need for effective, scalable interventions to prevent postoperative complications like delirium is more important than ever,” Faisal said in a news release.

ICU delirium is a serious condition that can lead to major complications and even death. Roughly 87 percent of patients who undergo major surgery involving intubation will experience some form of delirium coming out of anesthesia. Causes can range from infection to drug reactions. While many cases are mild, prolonged ICU delirium may prevent a patient from following medical advice or even cause them to hurt themselves.

Using VR games to treat delirium is a rapidly emerging and exciting branch of medicine. Studies show that VR games can help promote mental activity, memory and cognitive function. However, the full benefits are currently unknown as studies have been hampered by small patient populations.

Faisal believes that half of all ICU delirium cases are preventable through VR treatment. Currently, a general lack of knowledge and resources has been holding back the advancement of the treatment.

Hopefully, the work of Faisal in one of the busiest medical cities in the world can alleviate that problem as she spends the next half-decade plugging patients into games to aid in their healing.